Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson’s Disease
Open Access
- 28 February 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 9, 109
Abstract
Introduction: Impulse control disorders (ICDs) are frequent non-motor symptoms in Parkinson’s disease (PD), with potential negative effects on the quality of life and social functioning. ICDs are closely associated with dopaminergic therapy, and genetic polymorphisms in several neurotransmitter pathways may increase the risk of addictive behaviors in PD. However, clinical differentiation between patients at risk and patients without risk of ICDs is still troublesome. The aim of this study was to investigate if genetic polymorphisms across several neurotransmitter pathways were associated with ICD status in patients with PD. Methods: Whole-exome sequencing data were available for 119 eligible PD patients from the Norwegian ParkWest study. All participants underwent comprehensive neurological, neuropsychiatric, and neuropsychological assessments. ICDs were assessed using the self-report short form version of the Questionnaire for Impulsive-Compulsive Disorders in PD. Single-nucleotide polymorphisms (SNPs) from 17 genes were subjected to regression with elastic net penalization to identify candidate variants associated with ICDs. The area under the curve of receiver-operating characteristic curves was used to evaluate the level of ICD prediction. Results: Among the 119 patients with PD included in the analysis, 29% met the criteria for ICD and 63% were using dopamine agonists (DAs). Eleven SNPs were associated with ICDs, and the four SNPs with the most robust performance significantly increased ICD predictability (AUC = 0.81, 95% CI 0.73–0.90) compared to clinical data alone (DA use and age; AUC = 0.65, 95% CI 0.59–0.78). The strongest predictive factors were rs5326 in DRD1, which was associated with increased odds of ICDs, and rs702764 in OPRK1, which was associated with decreased odds of ICDs. Conclusion: Using an advanced statistical approach, we identified SNPs in nine genes, including a novel polymorphism in DRD1, with potential application for the identification of PD patients at risk for ICDs.Keywords
Funding Information
- Norges Forskningsråd (177966)
- Helse Vest (911218, 912014)
This publication has 57 references indexed in Scilit:
- GLMMLasso: An Algorithm for High-Dimensional Generalized Linear Mixed Models Using ℓ 1 -PenalizationJournal of Computational and Graphical Statistics, 2014
- Genetics of impulse control disorders in Parkinson’s diseaseJournal of Neural Transmission, 2012
- Developmental changes in human dopamine neurotransmission: cortical receptors and terminatorsBMC Neuroscience, 2012
- Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating ScaleMovement Disorders, 2011
- Frontostriatal Involvement in Task Switching Depends on Genetic Differences in D2 Receptor DensityThe Journal of Neuroscience, 2010
- Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's diseaseMovement Disorders, 2009
- SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMapBioinformatics, 2008
- Significant association of DRD1 with nicotine dependenceHuman Genetics, 2007
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- ParkinsonismNeurology, 1967